Literature DB >> 21993599

N-terminal pro-B-type natriuretic peptide level at long-term follow-up after atrial fibrillation ablation: a marker of reverse atrial remodelling and successful ablation.

Eivind Solheim1, Morten Kristian Off, Per Ivar Hoff, Alessandro De Bortoli, Peter Schuster, Ole-Jørgen Ohm, Jian Chen.   

Abstract

AIMS: We investigated the relationship between arrhythmia burden, left atrial volume (LAV) and N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) at baseline and after long-term follow-up of atrial fibrillation (AF) ablation.
METHODS: We studied 38 patients (23 paroxysmal, 6 women, mean age 56 ± 11) scheduled for AF ablation. LAV was calculated on the basis of computed tomography images at baseline and long-term follow-up, and arrhythmia burden was graded from self-reported frequency and duration of AF episodes.
RESULTS: After a mean period of 22 ± 5 months, 28/38 patients (11/15 persistent) were free from AF recurrence. At baseline there were no differences in mean LAV (125 vs. 130 cm(3), p = 0.7) or median NT-pro-BNP (33.5 vs. 29.5 pmol/L, p = 0.9) between patients whose ablation had been successful or otherwise. At long-term follow-up, there was a marked decrease in LAV (105 vs. 134 cm(3), p < 0.05) and level of NT-pro-BNP (7 vs. 17.5 pmol/L, p < 0.05) in the successful ablation patients. NT-pro-BNP correlated with LAV both at baseline (r = 0.71, p < 0.001) and at follow-up (r = 0.57, p < 0.001). Arrhythmia burden correlated with both NT-pro-BNP (r = 0.47, p < 0.01) and LAV (r = 0.52, p < 0.01). A decrease in NT-pro-BNP at follow-up of >25% of baseline value had a specificity of 0.89 and a sensitivity of 0.6 (receiver operator characteristics, accuracy 0.82) for ablation success.
CONCLUSIONS: NT-pro-BNP correlates with LAV and arrhythmia burden in AF patients and both NT-pro-BNP and LAV decrease significantly after successful ablation. A decrease in NT-pro-BNP of >25% from the baseline value could be useful as a marker of ablation success.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21993599     DOI: 10.1007/s10840-011-9629-2

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  31 in total

1.  Successful radiofrequency ablation in patients with previous atrial fibrillation results in a significant decrease in left atrial size.

Authors:  Willem P Beukema; Arif Elvan; Hauw T Sie; Anand R Ramdat Misier; Hein J J Wellens
Journal:  Circulation       Date:  2005-10-04       Impact factor: 29.690

2.  Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence.

Authors:  Gerhard Hindricks; Christopher Piorkowski; Hildegard Tanner; Richard Kobza; Jin-Hong Gerds-Li; Corrado Carbucicchio; Hans Kottkamp
Journal:  Circulation       Date:  2005-07-11       Impact factor: 29.690

3.  Assessment of left atrial volumes and phasic function using cine magnetic resonance imaging in normal subjects.

Authors:  V Järvinen; M Kupari; P Hekali; V P Poutanen
Journal:  Am J Cardiol       Date:  1994-06-01       Impact factor: 2.778

4.  Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation.

Authors:  A E Tuinenburg; B J Brundel; I C Van Gelder; R H Henning; M P Van Den Berg; C Driessen; J G Grandjean; W H Van Gilst; H J Crijns
Journal:  J Cardiovasc Electrophysiol       Date:  1999-06

5.  Characterization of the electroanatomical substrate in human atrial fibrillation: the relationship between changes in atrial volume, refractoriness, wavefront propagation velocities, and AF burden.

Authors:  Pipin Kojodjojo; Nicholas S Peters; D Wyn Davies; Prapa Kanagaratnam
Journal:  J Cardiovasc Electrophysiol       Date:  2007-03

6.  The impact of left atrial size on long-term outcome of catheter ablation of chronic atrial fibrillation.

Authors:  Li-Wei Lo; Yenn-Jiang Lin; Hsuan-Ming Tsao; Shih-Lin Chang; Ameya R Udyavar; Yu-Feng Hu; Kwo-Chang Ueng; Wen-Chin Tsai; Ta-Chun Tuan; Chien-Jung Chang; Wei-Hua Tang; Satoshi Higa; Ching-Tai Tai; Shih-Ann Chen
Journal:  J Cardiovasc Electrophysiol       Date:  2009-07-13

7.  Biatrial anatomical reverse remodelling after radiofrequency catheter ablation for atrial fibrillation: evidence from real-time three-dimensional echocardiography.

Authors:  Hajo Müller; Stephane Noble; Pierre-Frédéric Keller; Philippe Sigaud; Pascale Gentil; René Lerch; Dipen Shah; Haran Burri
Journal:  Europace       Date:  2008-07-14       Impact factor: 5.214

8.  N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study.

Authors:  Kristen K Patton; Patrick T Ellinor; Susan R Heckbert; Robert H Christenson; Christopher DeFilippi; John S Gottdiener; Richard A Kronmal
Journal:  Circulation       Date:  2009-10-19       Impact factor: 29.690

9.  Incremental predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide for short-term recurrence in atrial fibrillation ablation.

Authors:  Hye Jin Hwang; Jung Woo Son; Byung-Ho Nam; Boyoung Joung; Byungho Lee; Jin-Bae Kim; Moon-Hyoung Lee; Yangsoo Jang; Namsik Chung; Won-Heum Shim; Seung-Yun Cho; Sung Soon Kim
Journal:  Clin Res Cardiol       Date:  2009-02-19       Impact factor: 5.460

10.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.

Authors:  M C Wijffels; C J Kirchhof; R Dorland; M A Allessie
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

View more
  9 in total

Review 1.  Immunopathogenesis and biomarkers of recurrent atrial fibrillation following ablation therapy in patients with preexisting atrial fibrillation.

Authors:  John H Rosenberg; John H Werner; Gilman D Plitt; Victoria V Noble; Jordan T Spring; Brooke A Stephens; Aleem Siddique; Helenmari L Merritt-Genore; Michael J Moulton; Devendra K Agrawal
Journal:  Expert Rev Cardiovasc Ther       Date:  2018-12-29

2.  What Is High Enough? Elevated NT-pro-BNP in Decompensated Paroxysmal Supraventricular Tachycardia.

Authors:  Shawn Reeves; Clayton Womack; L O Lutherer; Christopher Todd; Kerrie Pinkney; Thivakorn Kasemsri
Journal:  J Pediatr Intensive Care       Date:  2017-06-12

Review 3.  Catheter Ablation of Atrial Fibrillation in Heart Failure: from Evidences to Guidelines.

Authors:  Arianna Cirasa; Carmelo La Greca; Domenico Pecora
Journal:  Curr Heart Fail Rep       Date:  2021-04-04

4.  Biomarkers in the clinical management of patients with atrial fibrillation and heart failure.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Mark Ainslie; Virginia Mplani; Georgia Karavasili; Nicholas Kounis; Grigorios Tsigkas
Journal:  J Geriatr Cardiol       Date:  2021-11-28       Impact factor: 3.327

5.  Determinants of Left Atrial Volume in Patients with Atrial Fibrillation.

Authors:  Matthias Bossard; Rahel Kreuzmann; Thomas Hochgruber; Philipp Krisai; Andreas J Zimmermann; Stefanie Aeschbacher; Katrin Pumpol; Arnheid Kessel-Schaefer; Frank-Peter Stephan; Nadja Handschin; Christian Sticherling; Stefan Osswald; Beat A Kaufmann; Guillaume Paré; Michael Kühne; David Conen
Journal:  PLoS One       Date:  2016-10-04       Impact factor: 3.240

6.  Multiple biomarkers and arrhythmia outcome following catheter ablation of atrial fibrillation: The Guangzhou Atrial Fibrillation Project.

Authors:  Hai Deng; Alena Shantsila; Pi Guo; Xianzhang Zhan; Xianhong Fang; Hongtao Liao; Yang Liu; Wei Wei; Lu Fu; Shulin Wu; Yumei Xue; Gregory Y H Lip
Journal:  J Arrhythm       Date:  2018-08-31

Review 7.  Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation.

Authors:  Masako Baba; Kentaro Yoshida; Masaki Ieda
Journal:  Int J Mol Sci       Date:  2019-06-10       Impact factor: 5.923

8.  Reduction in left atrial and pulmonary vein dimensions after ablation therapy is mediated by scar.

Authors:  Lisa A Gottlieb; Nora Al Jefairi; Dounia El Hamrani; Jérôme Naulin; Jérôme Lamy; Nadjia Kachenoura; Marion Constantin; Bruno Quesson; Hubert Cochet; Ruben Coronel; Lukas R C Dekker
Journal:  Int J Cardiol Heart Vasc       Date:  2021-10-23

9.  The impacts of contact force, power and application time on ablation effect indicated by serial measurements of impedance drop in both conventional and high-power short-duration ablation settings of atrial fibrillation.

Authors:  Li-Bin Shi; Yu-Chuan Wang; Song-Yun Chu; Alessandro De Bortoli; Peter Schuster; Eivind Solheim; Jian Chen
Journal:  J Interv Card Electrophysiol       Date:  2021-04-23       Impact factor: 1.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.